Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AstraZeneca and Bristol-Myers Squibb Diabetes Alliance awards grant to ADA

Jan. 20, 2014

Suglat tablets approved for treatment of type 2 diabetes in Japan

Jan. 17, 2014

Cytonet files MAA with EMA for use of liver cell therapy to treat urea cycle disorders in children

Jan. 17, 2014

Identification of a risk factor inversely correlated with cardiometabolic disease

Jan. 17, 2014

Chinese researchers report discovery of novel DPP IV inhibitors

Jan. 16, 2014

AG-348 activates mutant PKLR enzymes in patient-derived red cells

Jan. 16, 2014

Radius Health reports topline data from phase II abaloparatide study

Jan. 16, 2014

EMA committee recommends suspending use of Protelos/Osseor

Jan. 15, 2014

DiaMedica begins phase II trial of DM-199

Jan. 13, 2014

New mechanism of action for small-molecule antidiabetic drugs reported

Jan. 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...